EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Evaluation of the Antibacterial Potential of Reduced Graphene Oxide Against Methicillin-Resistant Staphylococcus aureus

Noor Abdul Ridha Al-Buhamrah1, Sabreen Ghanem Al-Fatlawi, Ibtihal Riyadh Najeeb, Noor Al-huda Nadhim Sadiq, Noor alhuda Ghanem Al-Fatlawi, Mohammed. K. S. Alquraishi

Ars Pharmaceutica (Internet) · 20.03.2026 · 67 (2) · 175-187

DOI: 10.30827/ars.v67i2.35268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ars Pharmaceutica (Internet), online erschienen am 20.03.2026. Verfasst von Noor Abdul Ridha Al-Buhamrah1 und 5 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Staphylococcus aureus is recognized for its role in diverse clinical conditions, especially causing severe manifestations in patients with suppressed immune function.

Methods

To evaluate bacterial presence, 24 clinical swab samples were systematically collected from suspected infection sites from patients in Najaf, Iraq. Bacterial culture yielded positive growth in 15 samples 62.5 %, and 10 isolates were confirmed as S. aureus through macroscopy, microscopy, biochemical tests, and VITEK 2 identification.

Results

Antibiotic susceptibility tests revealed high resistance rates, with 70 % of isolates resistant to ceftriaxone, followed by gentamicin, cephalosporin, erythromycin, and tetracycline, each at 60 %. Intermediate resistance was observed with chloramphenicol at 50 %, while the lowest rates were noted for rifampin and levofloxacin at 40 %. A significant proportion of the isolates 70 % exhibited resistance to multiple antimicrobial classes, while methicillin resistance was confirmed in 40 % of the S. aureus strains. When tested against these isolates, reduced graphene oxide (rGO) showed no inhibitory growth of S. aureus using the agar well diffusion assay.

Conclusion

The findings highlight a pressing demand for innovative treatment approaches to address this growing resistance, given the increasing resistance to antibiotics and the failure of unmodified rGO to provide effective bacterial inhibition under the conditions tested.

Zitieren

APA

Al-Buhamrah1, N. A. R., Al-Fatlawi, S. G., Najeeb, I. R., Sadiq, N. A. N., Al-Fatlawi, N. A. G., & Alquraishi, M. K. S. (2026). Evaluation of the Antibacterial Potential of Reduced Graphene Oxide Against Methicillin-Resistant Staphylococcus aureus. Ars Pharmaceutica (Internet), 67(2), 175-187. https://doi.org/10.30827/ars.v67i2.35268

Vancouver

Al-Buhamrah1 NAR, Al-Fatlawi SG, Najeeb IR, Sadiq NAN, Al-Fatlawi NAG, Alquraishi MKS. Evaluation of the Antibacterial Potential of Reduced Graphene Oxide Against Methicillin-Resistant Staphylococcus aureus. Ars Pharmaceutica (Internet). 2026;67(2):175-187. doi:10.30827/ars.v67i2.35268

BibTeX
@article{AlBuhamrah2026,
  author = {Al-Buhamrah1, Noor Abdul Ridha and Al-Fatlawi, Sabreen Ghanem and Najeeb, Ibtihal Riyadh and Sadiq, Noor Al-huda Nadhim and Al-Fatlawi, Noor alhuda Ghanem and Alquraishi, Mohammed. K. S.},
  title = {Evaluation of the Antibacterial Potential of Reduced Graphene Oxide Against Methicillin-Resistant Staphylococcus aureus},
  journal = {Ars Pharmaceutica (Internet)},
  year = {2026},
  volume = {67},
  number = {2},
  pages = {175--187},
  doi = {10.30827/ars.v67i2.35268}
}
Kostenlos starten →